3SBio hits the big time with $6 billion cancer drug deal
The pharma giant Pfizer has bought international rights to the experimental cancer therapy and will take a $100 million equity stake in the Chinese drug developer Key Takeaways: The mega…
Recent Articles
RELATED ARTICLES
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
- A blockbuster cancer drug? TYK’s claims go under the microscope
- Investors cheer Akeso’s revenue milestone, even as it returns to the red
- Will Trump’s drug order put the brakes on China’s overseas pharma drive?
- No respite for RemeGen as problems and losses pile up
